✦ LIBER ✦

Efficacy of methotrexate and tumor necrosis factor inhibitors in Japanese patients with active psoriatic arthritis

✍ Scribed by Mori, Yu; Kuwahara, Yoshiyuki; Chiba, Shinpei; Itoi, Eiji

Book ID: 126921725
Publisher: Springer
Year: 2014
Tongue: English
Weight: 186 KB
Volume: 25
Category: Article
ISSN: 1439-7595
DOI: 10.3109/14397595.2014.958891

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The comparative effectiveness of methotr

The comparative effectiveness of methotrexate and anti-tumor necrosis factor therapy in psoriatic arthritis

✍ Christopher T. Ritchlin 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 145 KB

Treatment of psoriatic arthritis and pso

Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab

✍ Edmund Cauza; Marita Spak; Karla Cauza; Ursula Hanusch-Enserer; Attila Dunky; Er 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 230 KB

Soluble Biomarkers Associated with Respo

Soluble Biomarkers Associated with Response to Treatment with Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis

✍ Chandran, V.; Shen, H.; Pollock, R. A.; Pellett, F. J.; Carty, A.; Cook, R. J.; 📂 Article 📅 2013 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 119 KB

Effect of tumor necrosis factor–alfa inh

Effect of tumor necrosis factor–alfa inhibitor and methotrexate therapy on total cholesterol, high-density lipoprotein, and low-density lipoprotein in psoriasis/psoriatic arthritis and rheumatoid arthritis patients

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Efficacy of additional methotrexate as a

Efficacy of additional methotrexate as a maintenance treatment in a Japanese patient with psoriatic arthritis refractory to infliximab monotherapy

✍ Yumi NONOMURA; Atsushi OTSUKA; Yoshiki MIYACHI; Kenji KABASHIMA; Miki TANIOKA 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 192 KB

Long Term Costs and Outcomes in Psoriati

Long Term Costs and Outcomes in Psoriatic Arthritis Patients Not Responding to Conventional Therapy Treated with Tumor Necrosis Factor Inhibitors: The Extension of Psoriatic Arthritis Cost Evaluation (PACE) Study

✍ Cortesi, P.A.; Olivieri, I.; de Portu, S.; Salvarani, C.; Cauli, A.; Lubrano, E. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB